Sino Biopharmaceutical (01177) said its profit attributable to the owners of the parent for the first quarter ended 31 March 2018 rose 33.2% year-on-year to Rmb771 million.
Basic and diluted earnings per share were Rmb9.94 cents.
Revenue amounted to Rmb4,653 million, an increase of 20.4% from a year earlier.
The board of directors has declared the payment of a first quarterly dividend of HK2 cents (2017: HK1.5 cents) per share, payable on 25 June.
全新etnet健康網購，送你【健骨維他命D3(1000IU)】乙樽(價值$108)► 立即行動！
